EMPAGLIFLOZIN

69480 reported adverse events

Drug classes: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]

These side effects are most commonly reported by patients taking EMPAGLIFLOZIN:

# Side effect Count
0 DIABETIC KETOACIDOSIS 3903
1 NAUSEA 3728
2 DIARRHOEA 3406
3 BLOOD GLUCOSE INCREASED 3255
4 FATIGUE 3031
5 WEIGHT DECREASED 3000
6 OFF LABEL USE 2916
7 VOMITING 2802
8 DIZZINESS 2775
9 DYSPNOEA 2526
See all common reactions for EMPAGLIFLOZIN

EMPAGLIFLOZIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EUGLYCAEMIC DIABETIC KETOACIDOSIS 2079 0.5030
1 KETOACIDOSIS 1524 0.2034
2 DIABETIC KETOACIDOSIS 3903 0.1623
3 NECROTISING FASCIITIS 254 0.0720
4 FUNGAL INFECTION 2167 0.0650
5 IMPAIRED GASTRIC EMPTYING 701 0.0514
6 GLYCOSYLATED HAEMOGLOBIN INCREASED 1262 0.0500
7 BLOOD GLUCOSE ABNORMAL 621 0.0336
8 GLOMERULAR FILTRATION RATE DECREASED 391 0.0318
9 UROSEPSIS 272 0.0295
See all enriched reactions for EMPAGLIFLOZIN